Skip to main content
. 2019 Mar 18;54(5):1511–1524. doi: 10.3892/ijo.2019.4751

Table VI.

ncRNAs involved in taxane resistance in gastric cancer.

Drug NcRNA Dysregulation Effect on drug resistance Target/pathway Refs.
Paclitaxel miR-34c-5p Reversing MAPT (141)
Docetaxel miR-361-5p Reversing Autophagy/PI3K/Akt/mTOR (142)
Cabazitaxel / / / / /
Abraxane / / / / /

MAPT, microtubule-associated protein tau; PI3K, phosphoinositide 3-kinase; Akt, protein kinase B; mTOR, mammalian target of rapamycin; /, not mentioned; ↑, upregulation; ↓, downregulation.